Ricardo Giscombe

2.1k total citations
41 papers, 1.7k citations indexed

About

Ricardo Giscombe is a scholar working on Immunology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ricardo Giscombe has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 13 papers in Neurology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ricardo Giscombe's work include Myasthenia Gravis and Thymoma (13 papers), T-cell and B-cell Immunology (12 papers) and Vasculitis and related conditions (10 papers). Ricardo Giscombe is often cited by papers focused on Myasthenia Gravis and Thymoma (13 papers), T-cell and B-cell Immunology (12 papers) and Vasculitis and related conditions (10 papers). Ricardo Giscombe collaborates with scholars based in Sweden, China and United Kingdom. Ricardo Giscombe's co-authors include Ann Kari Lefvert, Ritva Pirskanen, DeRen Huang, Xiongbiao Wang, Ann‐Kari Lefvert, Ming Gu, Xinyu Zhao, Yuping Sun, Jianqiang Zhao and Yunshan Wang and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and European Journal of Immunology.

In The Last Decade

Ricardo Giscombe

41 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo Giscombe Sweden 23 1.1k 415 323 301 231 41 1.7k
Hirofumi Shoda Japan 23 1.1k 1.0× 432 1.0× 104 0.3× 211 0.7× 515 2.2× 100 2.0k
Taichi Hayashi Japan 23 735 0.7× 214 0.5× 129 0.4× 264 0.9× 697 3.0× 95 1.8k
Grace M. Thomas United States 12 970 0.9× 160 0.4× 193 0.6× 265 0.9× 67 0.3× 24 1.8k
Beverly W. Baron United States 20 623 0.6× 359 0.9× 118 0.4× 120 0.4× 64 0.3× 55 1.8k
Paul A. Chervenick United States 21 493 0.5× 466 1.1× 201 0.6× 154 0.5× 84 0.4× 40 1.7k
Keiko Yoshimoto Japan 24 946 0.9× 243 0.6× 116 0.4× 198 0.7× 555 2.4× 84 1.7k
Stella Arelaki Greece 13 1.1k 1.0× 140 0.3× 145 0.4× 368 1.2× 133 0.6× 21 1.6k
Kazuma Ikeda Japan 23 476 0.5× 470 1.1× 79 0.2× 111 0.4× 64 0.3× 106 1.6k
Serge Jacquot France 17 871 0.8× 169 0.4× 159 0.5× 91 0.3× 393 1.7× 30 1.6k
Travis J. Hollmann United States 14 941 0.9× 121 0.3× 87 0.3× 99 0.3× 614 2.7× 21 1.8k

Countries citing papers authored by Ricardo Giscombe

Since Specialization
Citations

This map shows the geographic impact of Ricardo Giscombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Giscombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Giscombe more than expected).

Fields of papers citing papers by Ricardo Giscombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Giscombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Giscombe. The network helps show where Ricardo Giscombe may publish in the future.

Co-authorship network of co-authors of Ricardo Giscombe

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Giscombe. A scholar is included among the top collaborators of Ricardo Giscombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Giscombe. Ricardo Giscombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ritter, Markus, Husameldin El‐Nour, Mari‐Anne Hedblad, et al.. (2012). Serotonin and its 5-HT1 receptor in human mastocytosis. Immunopharmacology and Immunotoxicology. 34(4). 679–685. 12 indexed citations
2.
Gu, Ming, Maria Kakoulidou, Ricardo Giscombe, et al.. (2008). Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis. Clinical Immunology. 128(3). 374–381. 25 indexed citations
3.
Kakoulidou, Maria, Ricardo Giscombe, Xiao‐Fan Zhao, Ann Kari Lefvert, & X. Wang. (2007). Human Soluble CD80 is Generated by Alternative Splicing, and Recombinant Soluble CD80 Binds to CD28 and CD152 Influencing T‐cell Activation. Scandinavian Journal of Immunology. 66(5). 529–537. 29 indexed citations
4.
Pirskanen, Ritva, et al.. (2007). Two SNPs in the promoter region of the CTLA‐4 gene affect binding of transcription factors and are associated with human myasthenia gravis. Journal of Internal Medicine. 263(1). 61–69. 64 indexed citations
5.
Kakoulidou, Maria, et al.. (2004). The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis. Journal of Neuroimmunology. 148(1-2). 183–191. 10 indexed citations
6.
Zhao, Xinyu, et al.. (2002). A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein. Genes and Immunity. 3(4). 233–234. 172 indexed citations
7.
Giscombe, Ricardo, et al.. (2002). Expression of CTLA‐4 by Human Monocytes. Scandinavian Journal of Immunology. 55(1). 53–60. 81 indexed citations
8.
Kakoulidou, Maria, Qianhui Qiu, Ricardo Giscombe, et al.. (2002). CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes and Immunity. 3(1). 46–49. 35 indexed citations
9.
Wang, Xiongbiao, Maria Kakoulidou, Ricardo Giscombe, et al.. (2002). Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. Journal of Neuroimmunology. 130(1-2). 224–232. 122 indexed citations
10.
Zheng, Chengyun, et al.. (2001). Regulation of Surface and Intracellular Expression of CTLA‐4 on Human Peripheral T Cells. Scandinavian Journal of Immunology. 54(5). 453–458. 70 indexed citations
11.
Huang, DeRen, et al.. (2000). Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. Journal of Neuroimmunology. 105(1). 69–77. 65 indexed citations
12.
Giscombe, Ricardo, Xiongbiao Wang, & Ann Kari Lefvert. (2000). Polymorphisms at the promoter region of the CTLA-4 gene are associated with Wegener's granulomatosis in a Swedish population. Atherosclerosis. 151(1). 73–73. 1 indexed citations
13.
Huang, DeRen, Chengyun Zheng, Ricardo Giscombe, et al.. (1999). Polymorphisms at −174 and in the 3′ flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis. Journal of Neuroimmunology. 101(2). 197–200. 24 indexed citations
14.
Giscombe, Ricardo, Soniya Nityanand, Nongnit Lewin, Johan Grünewald, & Ann Kari Lefvert. (1998). Expanded T Cell Populations in Patients with Wegener's Granulomatosis: Characteristics and Correlates with Disease Activity. Journal of Clinical Immunology. 18(6). 404–413. 45 indexed citations
15.
Hjelmström, Peter, Christopher S. Peacock, Ricardo Giscombe, et al.. (1998). Myasthenia Gravis with Thymic Hyperplasia Is Associated with Polymorphisms in the Tumor Necrosis Factor Region. Annals of the New York Academy of Sciences. 841(1). 368–370. 6 indexed citations
16.
Hjelmström, Peter, Christopher S. Peacock, Ricardo Giscombe, et al.. (1998). Polymorphism in tumor necrosis factor genes associated with myasthenia gravis. Journal of Neuroimmunology. 88(1-2). 137–143. 23 indexed citations
17.
Wu, Rongqian, Ricardo Giscombe, G. Holm, & Ann‐Kari Lefvert. (1996). Induction of Human Cytotoxic T Lymphocytes by Oxidized Low Density Lipoproteins. Scandinavian Journal of Immunology. 43(4). 381–384. 13 indexed citations
18.
Hjelmström, Peter, Ricardo Giscombe, Ann Kari Lefvert, et al.. (1995). Different HLA-DQ are Positively and Negatively Associated in Swedish Patients with Myasthenia Gravis. Autoimmunity. 22(1). 59–65. 28 indexed citations
19.
Vázquez, Ana, Ricardo Giscombe, Ignacio J. Ansotegui, et al.. (1992). Characterization of the Colorectal Antigen IOR-C2. Hybridoma. 11(2). 245–256. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirofumi Shoda Breakdown of academic impact, for papers by Taichi Hayashi Breakdown of academic impact, for papers by Grace M. Thomas Breakdown of academic impact, for papers by Beverly W. Baron Breakdown of academic impact, for papers by Paul A. Chervenick Breakdown of academic impact, for papers by Keiko Yoshimoto Breakdown of academic impact, for papers by Stella Arelaki Breakdown of academic impact, for papers by Kazuma Ikeda Breakdown of academic impact, for papers by Serge Jacquot Breakdown of academic impact, for papers by Travis J. Hollmann
Rankless by CCL
2026